Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.

Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a ...

If you’re trying to figure out whether now’s the time to buy, hold, or even sell DexCom stock, you’re not alone. After all, its share price has been a bit of a roller coaster lately. Over the last ...

Stick with your squad, or at least close to a Support player. The Adrenaline Injector has a very long cooldown, and you can ...

In addition to the graphics and processor hardware requirements -- fairly meaningless for a handheld -- the always-on ...

DexCom is down 16.6% since the beginning of the year, and at $65.44 per share, it is trading 27.9% below its 52-week high of $90.75 from February 2025. Investors who bought $1,000 worth of DexCom’s ...

Valued at a market cap of $25.5 billion, DexCom, Inc. (DXCM) is a medical device company that designs, develops, and ...

Shares of DexCom Inc. DXCM slipped 4.35% to $65.12 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 2.71% to 6,552.51 and Dow ...

Experts weigh in on the most promising AI applications, from diabetic retinopathy screening to smarter insulin delivery, and ...

Master every vehicle in Battlefield 6 with this comprehensive guide. Learn the strengths, loadouts, and tactics for all tanks ...

MLB scores for Oct. 6 games are available on usatoday.com. Here's how to access today's results: See scores, results for all the games listed above. See MLB Scores, results from Oct. 5 Our team of ...